Cargando…

β-blockers augment L-type Ca(2+) channel activity by targeting spatially restricted β(2)AR signaling in neurons

G protein-coupled receptors (GPCRs) transduce pleiotropic intracellular signals in mammalian cells. Here, we report neuronal excitability of β-blockers carvedilol and alprenolol at clinically relevant nanomolar concentrations. Carvedilol and alprenolol activate β(2)AR, which promote G protein signal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Ao, Chen, Dana, Kaur, Manpreet, Bartels, Peter, Xu, Bing, Shi, Qian, Martinez, Joseph M, Man, Kwun-nok Mimi, Nieves-Cintron, Madeline, Hell, Johannes W, Navedo, Manuel F, Yu, Xi-Yong, Xiang, Yang K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	eLife Sciences Publications, Ltd 2019
Materias:	Cell Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813027/ https://www.ncbi.nlm.nih.gov/pubmed/31609201 http://dx.doi.org/10.7554/eLife.49464

Ejemplares similares

α(1)-Adrenergic receptor–PKC–Pyk2–Src signaling boosts L-type Ca(2+) channel Ca(V)1.2 activity and long-term potentiation in rodents
por: Man, Kwun Nok Mimi, et al.
Publicado: (2023)

Half-calcified calmodulin promotes basal activity and inactivation of the L-type calcium channel Ca(V)1.2
por: Bartels, Peter, et al.
Publicado: (2022)

Spatiotemporal Control of Vascular Ca(V)1.2 by α1(C) S1928 Phosphorylation
por: Martín-Aragón Baudel, Miguel, et al.
Publicado: (2022)

β-blockers Reverse Agonist-Induced β(2)-AR Downregulation Regardless of Their Signaling Profile
por: Maccari, Sonia, et al.
Publicado: (2020)

Functionally distinct and selectively phosphorylated GPCR subpopulations co-exist in a single cell
por: Shen, Ao, et al.
Publicado: (2018)

Dynamic L-type Ca(V)1.2 channel trafficking facilitates Ca(V)1.2 clustering and cooperative gating
por: Ghosh, Debapriya, et al.
Publicado: (2018)

SparkMaster 2: A New Software for Automatic Analysis of Calcium Spark Data
por: Tomek, Jakub, et al.
Publicado: (2023)

β-AR Blockers Suppresses ER Stress in Cardiac Hypertrophy and Heart Failure
por: Ni, Li, et al.
Publicado: (2011)

In silico identification of a β(2)-adrenoceptor allosteric site that selectively augments canonical β(2)AR-Gs signaling and function
por: Shah, Sushrut D., et al.
Publicado: (2022)

Age-Dependent Contributions of NMDA Receptors and L-Type Calcium Channels to Long-Term Depression in the Piriform Cortex
por: Rajani, Vishaal, et al.
Publicado: (2021)

Purinergic Signaling During Hyperglycemia in Vascular Smooth Muscle Cells
por: Martin-Aragon Baudel, Miguel, et al.
Publicado: (2020)

Analysis of β(2)AR-G(s) and β(2)AR-G(i) complex formation by NMR spectroscopy
por: Ma, Xiuyan, et al.
Publicado: (2020)

Secondhand Smoke Exposure Impairs Ion Channel Function and Contractility of Mesenteric Arteries
por: Le, Thanhmai, et al.
Publicado: (2021)

Signal profiling of the β(1)AR reveals coupling to novel signalling pathways and distinct phenotypic responses mediated by β(1)AR and β(2)AR
por: Lukasheva, Viktoriya, et al.
Publicado: (2020)

β2AR Antagonists and β2AR Gene Deletion Both Promote Skin Wound Repair Processes
por: Pullar, Christine E, et al.
Publicado: (2012)

Ion channel molecular complexes in vascular smooth muscle
por: Pereira da Silva, Eric A., et al.
Publicado: (2022)

Impaired BK(Ca) channel function in native vascular smooth muscle from humans with type 2 diabetes
por: Nieves-Cintrón, Madeline, et al.
Publicado: (2017)

Cellular and molecular effects of hyperglycemia on ion channels in vascular smooth muscle
por: Nieves-Cintrón, Madeline, et al.
Publicado: (2020)

Comparison of ivabradine plus β-blockers versus β-blocker therapy only
por: Aalbers, J
Publicado: (2010)

Biased activation of β(2)-AR/Gi/GRK2 signal pathway attenuated β(1)-AR sustained activation induced by β(1)-adrenergic receptor autoantibody
por: Chen, Hao, et al.
Publicado: (2021)

Short-term effects of β2-AR blocker ICI 118,551 on sarcoplasmic reticulum SERCA2a and cardiac function of rats with heart failure
por: Gong, Haibin, et al.
Publicado: (2016)

Microtubule-Mediated Regulation of β(2)AR Translation and Function in Failing Hearts
por: Kwan, Zoe, et al.
Publicado: (2023)

Quantitative Modeling of GRK-Mediated β2AR Regulation
por: Vayttaden, Sharat J., et al.
Publicado: (2010)

β(2)ARs: double edge sword in heart function
por: Beasley, Heather K., et al.
Publicado: (2023)

β blockers for heart failure
por: Hoes, Arno W
Publicado: (2016)

β1-blocker in sepsis
por: Hasegawa, Daisuke, et al.
Publicado: (2021)

AKAP5 complex facilitates purinergic modulation of vascular L-type Ca(2+) channel Ca(V)1.2
por: Prada, Maria Paz, et al.
Publicado: (2020)

β‐adrenergic‐mediated dynamic augmentation of sarcolemmal Ca(V)1.2 clustering and co‐operativity in ventricular myocytes
por: Ito, Danica W., et al.
Publicado: (2019)

Diuretic and β-Blocker in Hypertension—Then What?
por: Ramsay, L. E.
Publicado: (1980)

Pro-survival function of MEF2 in cardiomyocytes is enhanced by β-blockers
por: Hashemi, S, et al.
Publicado: (2015)

Heart Failure and MEF2 Transcriptome Dynamics in Response to β-Blockers
por: Tobin, S. W., et al.
Publicado: (2017)

Enhanced β(2)-adrenergic receptor (β(2)AR) signaling by adeno-associated viral (AAV)-mediated gene transfer
por: Jones, Stacie M, et al.
Publicado: (2003)

Computational design and characterization of nanobody-derived peptides that stabilize the active conformation of the β(2)-adrenergic receptor (β(2)-AR)
por: Sencanski, Milan, et al.
Publicado: (2019)

A G(s)-coupled purinergic receptor boosts Ca(2+) influx and vascular contractility during diabetic hyperglycemia
por: Prada, Maria Paz, et al.
Publicado: (2019)

The β-blocker Nebivolol Is a GRK/β-arrestin Biased Agonist
por: Erickson, Catherine E., et al.
Publicado: (2013)

Mechanisms Underlying Heterogeneous Ca(2+) Sparklet Activity in Arterial Smooth Muscle
por: Navedo, Manuel F., et al.
Publicado: (2006)

Should β-blockers be used in septic shock?
por: Lira, Alena, et al.
Publicado: (2014)

Systematic review of use of β-blockers in sepsis
por: Chacko, Cyril Jacob, et al.
Publicado: (2015)

Immunologic adverse reactions of β-blockers and the skin
por: Tatu, Alin Laurentiu, et al.
Publicado: (2019)

β-Blockers Improve Presinusoidal Portal Hypertension
por: Sørensen, Michael, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jeslj3peoi7cjo7khttgaje74f